See also this year's filing and all EDGAR filings for this company.
PDF Report 0001645469_2023_Monopar_Therapeutics.pdf
Logs
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001645469, Monopar Therapeutics
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 13,165,726 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 61,228 |
4 | LiabilitiesCurrent | 3,128,894 |
5 | LiabilitiesNoncurrent | 8,408 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 2,945,276 |
9 | ResearchAndDevelopmentExpense | 7,591,601 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 21,239 |
13 | remainder_ComprehensiveNetIncome | 12,102 |
yvar | yval | |
---|---|---|
0 | Assets | 13,226,954 |
1 | Liabilities | 3,137,302 |
2 | Expenses | 10,536,877 |
3 | Revenues | 0 |
4 | StockholdersEquity | 10,089,652 |
5 | NetIncome | -10,515,638 |
6 | ComprehensiveNetIncome | -10,509,587 |
7 | BaseVar | 13,467,237 |
8 | EconomicCapitalRatio | 0.837 |